ALI HEALTH
00241
BILIBILI-W
09626
KUAISHOU-W
01024
JD-SW
09618
JD HEALTH
06618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -111.83%-130.82M | ---- | -459.52%-61.76M | ---- | -64.77%17.18M | ---- | 151.12%48.76M | ---- | -41.22%-95.38M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 75.00%-1K | ---- | 63.64%-4K | ---- | 45.00%-11K | ---- | 93.71%-20K | ---- | 20.70%-318K |
Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -11.76%-76K |
Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | -119.71%-7.11M | ---- | 58.56%-3.24M | ---- | -175.94%-7.81M |
Impairment and provisions: | ---- | -29.90%38.03M | ---- | 17.71%54.24M | ---- | -0.03%46.08M | ---- | 21.56%46.1M | ---- | 891.36%37.92M |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | -58.04%5.16M | ---- | --12.3M | ---- | ---- |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 16.01%2.55M |
-Other impairments and provisions | ---- | -29.90%38.03M | ---- | 32.55%54.24M | ---- | 21.07%40.92M | ---- | -4.45%33.8M | ---- | 1,146.37%35.37M |
Revaluation surplus: | ---- | -84.85%7.87M | ---- | 129.90%51.95M | ---- | 192.85%22.6M | ---- | -292.73%-24.34M | ---- | -40.70%12.63M |
-Fair value of investment properties (increase) | ---- | -84.85%7.87M | ---- | 129.90%51.95M | ---- | 192.85%22.6M | ---- | -292.73%-24.34M | ---- | -40.70%12.63M |
Asset sale loss (gain): | ---- | --57.05M | ---- | ---- | ---- | ---- | ---- | ---1.27M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.27M | ---- | ---- |
-Loss (gain) from selling other assets | ---- | --57.05M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | -8.78%2.58M | ---- | -11.25%2.82M | ---- | -29.26%3.18M | ---- | -50.53%4.5M | ---- | 65.89%9.09M |
-Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -62.81%829K |
Financial expense | ---- | -16.81%7.53M | ---- | -16.68%9.05M | ---- | 0.72%10.86M | ---- | 14.13%10.78M | ---- | 133.77%9.45M |
Special items | ---- | 1,447.52%22.54M | ---- | 73.24%-1.67M | ---- | -94.04%-6.25M | ---- | -113.27%-3.22M | ---- | -17.01%24.28M |
Operating profit before the change of operating capital | ---- | -91.25%4.78M | ---- | -36.86%54.64M | ---- | 10.86%86.53M | ---- | 863.55%78.05M | ---- | 59.25%-10.22M |
Change of operating capital | ||||||||||
Developing property (increase)decrease | ---- | ---- | ---- | ---- | ---- | -238.71%-210K | ---- | 91.41%-62K | ---- | -55.27%-722K |
Accounts receivable (increase)decrease | ---- | -130.34%-10.42M | ---- | 159.42%34.35M | ---- | -1,140.41%-57.8M | ---- | 58.45%-4.66M | ---- | -111.62%-11.22M |
Accounts payable increase (decrease) | ---- | 40.63%16.58M | ---- | -36.90%11.79M | ---- | 563.90%18.69M | ---- | 69.96%-4.03M | ---- | -422.89%-13.41M |
Special items for working capital changes | ---- | 103.54%3.17M | ---- | -25.90%-89.33M | ---- | -24.88%-70.95M | ---- | -129.22%-56.82M | ---- | 81.12%-24.79M |
Cash from business operations | ---- | 23.22%14.11M | ---- | 148.20%11.45M | ---- | -290.26%-23.75M | ---- | 120.68%12.48M | ---- | 4.08%-60.35M |
Hong Kong profits tax paid | ---- | 99.51%-29K | ---- | 2.83%-5.93M | ---- | -693.12%-6.11M | ---- | -1.32%-770K | ---- | -2,520.69%-760K |
Special items of business | -206.73%-3.52M | ---- | -82.21%3.3M | ---- | 240.54%18.55M | ---- | -479.12%-13.2M | ---- | 107.96%3.48M | ---- |
Net cash from operations | -206.73%-3.52M | 155.30%14.08M | -82.21%3.3M | 118.47%5.51M | 240.54%18.55M | -354.90%-29.86M | -479.12%-13.2M | 119.17%11.71M | 107.96%3.48M | 2.92%-61.11M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -75.00%1K | ---- | -63.64%4K | ---- | -45.00%11K | ---- | -93.71%20K | ---- | -20.70%318K |
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 11.76%76K |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 479.93%8.53M |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.07M | ---- | ---- |
Purchase of fixed assets | ---- | ---- | ---- | -20,000.00%-1.01M | ---- | 0.00%-5K | ---- | 99.78%-5K | ---- | -198.57%-2.28M |
Recovery of cash from investments | ---- | ---- | ---- | --29.07M | ---- | ---- | ---- | ---- | ---- | --3.18M |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -80.68%-4.68M |
Other items in the investment business | ---- | ---- | 153.81%1.34M | ---- | ---2.5M | ---- | ---- | ---- | -2,210.52%-11.04M | ---- |
Net cash from investment operations | ---- | -100.00%1K | 153.81%1.34M | 467,650.00%28.07M | ---2.5M | -99.71%6K | ---- | -59.34%2.09M | -2,210.52%-11.04M | -64.62%5.14M |
Net cash before financing | -175.86%-3.52M | -58.07%14.08M | -71.07%4.64M | 212.48%33.58M | 221.63%16.05M | -316.28%-29.85M | -74.63%-13.2M | 124.66%13.8M | 82.51%-7.56M | -15.58%-55.98M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 323.08%7.7M | ---- | -90.16%1.82M | ---- | -41.25%18.5M | ---- | -56.84%31.49M | ---- | 111.58%72.97M |
Refund | ---- | 61.93%-8.27M | ---- | -40.46%-21.71M | ---- | 40.00%-15.46M | ---- | 46.00%-25.77M | ---- | -1,532.26%-47.71M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --60.16M | ---- | ---- | ---- | --14.77M |
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20M |
Interest paid - financing | ---- | 16.81%-7.53M | ---- | 17.97%-9.05M | ---- | -6.15%-11.03M | ---- | -11.75%-10.39M | ---- | -130.11%-9.3M |
Issuance expenses and redemption of securities expenses | ---- | 66.94%-2.38M | ---- | 17.71%-7.2M | ---- | 8.69%-8.75M | ---- | 17.86%-9.58M | ---- | ---11.67M |
Other items of the financing business | 203.72%4.43M | ---- | 75.49%-4.28M | ---- | -393.88%-17.44M | ---- | 234.31%5.94M | ---- | -112.08%-4.42M | ---- |
Net cash from financing operations | 203.72%4.43M | 27.00%-34.64M | 75.49%-4.28M | -232.76%-47.45M | -393.88%-17.44M | 271.78%35.74M | 234.31%5.94M | -159.84%-20.81M | -112.08%-4.42M | 26.35%34.77M |
Effect of rate | 96.00%-3K | 1,347.90%20.24M | 98.74%-75K | -37.23%-1.62M | ---5.97M | -602.98%-1.18M | ---- | 125.38%235K | 139.77%346K | -671.67%-926K |
Net Cash | 147.83%912K | -48.21%-20.56M | 126.46%368K | -335.49%-13.87M | 80.85%-1.39M | 184.10%5.89M | 39.36%-7.26M | 66.96%-7.01M | -80.74%-11.98M | -1.42%-21.2M |
Begining period cash | -32.96%651K | -94.10%971K | -94.10%971K | 40.05%16.47M | 40.05%16.47M | -36.54%11.76M | -36.54%11.76M | -54.43%18.53M | -54.43%18.53M | -34.09%40.65M |
Cash at the end | 23.42%1.56M | -32.96%651K | -86.11%1.26M | -94.10%971K | 102.47%9.1M | 40.05%16.47M | -34.83%4.5M | -36.54%11.76M | -79.20%6.9M | -54.43%18.53M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | 40.05%16.47M | ---- | -36.54%11.76M | ---- | --18.53M |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | 40.05%16.47M | ---- | -36.54%11.76M | ---- | --18.53M |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | China Credit Letter (Hong Kong) Certified Public Accountants Limited | -- | China Credit Letter (Hong Kong) Certified Public Accountants Limited | -- | China Credit Letter (Hong Kong) Certified Public Accountants Limited | -- | -- | -- | Zheng Zheng Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.